Clinical Trial Update: Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the linearity of exposure and the comparative bioavailability of treprostinil diethanolamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil diethanolamine (treprostinil diethanolamine)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED